Growing demand for treatments targeting rare disorders and favorable regulatory pathways are propelling the global orphan drugs market toward strong expansion. https://www.einpresswire.com/article/834691992/orphan-drugs-market-to-reach-usd-486-51-billion-by-2032-on-rare-disease-focus-datam-intelligence